Fanny Cavalie - 21 Jun 2024 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Strategy/Bus Ops Officer
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Fanny Cavalie
Issuer symbol
FHTX
Transactions as of
21 Jun 2024
Net transactions value
$0
Form type
4
Filing time
24 Jun 2024, 16:01:17 UTC
Previous filing
12 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FHTX Common Stock 86,992 21 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding FHTX Stock Options (Right to buy) 5,575 21 Jun 2024 Common Stock 5,575 $0.7300 Direct F1
holding FHTX Stock Options (Right to buy) 10,135 21 Jun 2024 Common Stock 10,135 $3.72 Direct F2
holding FHTX Stock Options (Right to buy) 59,459 21 Jun 2024 Common Stock 59,459 $8.77 Direct F3
holding FHTX Stock Options (Right to buy) 50,000 21 Jun 2024 Common Stock 50,000 $16.63 Direct F4
holding FHTX Stock Options (Right to buy) 125,000 21 Jun 2024 Common Stock 125,000 $14.87 Direct F5
holding FHTX Stock Options (Right to buy) 65,000 21 Jun 2024 Common Stock 65,000 $8.38 Direct F6
holding FHTX Stock Options (Right to buy) 80,000 21 Jun 2024 Common Stock 80,000 $3.06 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Fanny Cavalie is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The option vested as to 25% of the underlying shares of common stock on March 19, 2019, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.
F2 The option vested as to 25% of the underlying shares of common stock on January 30, 2020, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.
F3 The option vested as to 25% of the underlying shares of common stock on August 18, 2021, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.
F4 The option vested as to 25% of the underlying shares of common stock on January 28, 2022, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.
F5 The option vested as to 25% of the underlying shares of common stock on January 26, 2023, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.
F6 The option vested as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.
F7 The option vests as to 25% of the underlying shares of common stock on January 24, 2025, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.

Remarks:

Exit Form 4 filed solely to report the Reporting Person is no longer an officer of the Issuer within the meaning of Rule 16a-1 of the Securities Exchange Act of 1934, as amended.